California Oncology Weekly Newsletter 10.3.2017

breast cancer care

This Weekly’s Hot Topics

In honor of Breast Cancer Awareness Month, we acknowledge those physicians, clinicians and people who give hope and push forward on behalf of those women and men battling the disease.

CalPERS Open Enrollment is September 11th through October 6th. You are encouraged to assist your CalPERS patients as to what to keep in mind when changing their health plan. For more information click here and go to California News.

The Institute for Clinical and Economic Review (ICER) issued a final evidence report confirming that there is inadequate evidence to compare outcomes of PARP inhibitors for ovarian cancer. Advantages of oral treatment and lower side effects noted, but evidence judged inadequate to determine which patients stand to benefit from maintenance therapy. For more information click here and go to National News.

Yesterday, October 2nd was the deadline to begin reporting one or more quality measures, improvement activities, or Advancing Care Information measures for the minimum 90 consecutive days for group practices and eligible clinicians (ECs) to earn a bonus in the Merit-Based Incentive Payment System (MIPS) in 2019. For more information click here and go to CMS News.

For the past few years PBM’s (pharmacy benefit managers) have allowed many in-office pharmacy dispensing to be in-network to dispense drugs to patients, but have only allowed the initial script to be filled. All subsequent scripts are to be filled by a specialty pharmacy of the PBM’s choosing. For more information click here and go to Affiliate Association News.

To view the complete California Oncology weekly Newsletter, click on the date below.

October 3, 2017



No comments have been posted yet.